Ligand validation:8IY2

3AM: [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] dihydrogen phosphate

3AM is a Ligand Of Interest in 8IY2 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Model completeness	Average occupancy
8IY2_3AM_C_204	57%	59%	0.174	0.959	0.69	0.89	-	1	0	96%	0.3157
8IY2_3AM_C_205	57%	57%	0.175	0.958	0.67	0.99	-	2	0	96%	0.3157
8IY2_3AM_D_203	56%	60%	0.179	0.958	0.68	0.85	-	1	0	96%	0.3157
8IY2_3AM_C_203	56%	57%	0.179	0.958	0.66	0.97	-	2	0	96%	0.3157
8IY2_3AM_D_205	55%	59%	0.181	0.959	0.67	0.9	-	1	0	96%	0.3157
8IY2_3AM_D_204	54%	59%	0.184	0.957	0.68	0.9	-	1	0	96%	0.3157
8IY2_3AM_A_206	50%	59%	0.198	0.959	0.69	0.87	-	1	0	96%	0.3252
8IY2_3AM_E_205	49%	57%	0.187	0.943	0.69	0.96	-	2	0	96%	0.3157
8IY2_3AM_A_204	49%	58%	0.203	0.958	0.69	0.9	-	1	0	96%	0.3252
8IY2_3AM_A_205	49%	56%	0.197	0.951	0.68	1	-	2	1	96%	0.3252
8IY2_3AM_B_203	47%	59%	0.194	0.942	0.68	0.87	-	1	0	96%	0.3157
8IY2_3AM_D_206	47%	56%	0.199	0.947	0.7	0.97	-	2	1	96%	0.9565
8IY2_3AM_B_207	46%	56%	0.199	0.943	0.69	1.01	-	2	0	96%	0.4687
8IY2_3AM_E_203	45%	61%	0.2	0.941	0.65	0.85	-	1	0	96%	0.3157
8IY2_3AM_E_204	44%	59%	0.194	0.93	0.66	0.89	-	1	0	96%	0.3157
8IY2_3AM_B_205	44%	59%	0.203	0.938	0.66	0.92	-	2	1	96%	0.3157
8IY2_3AM_F_205	43%	55%	0.192	0.922	0.68	1.03	-	2	0	96%	0.3061
8IY2_3AM_F_203	41%	57%	0.204	0.928	0.68	0.98	-	2	0	96%	0.3061
8IY2_3AM_F_204	41%	56%	0.195	0.917	0.69	1	-	2	0	96%	0.3061
8IY2_3AM_B_204	40%	57%	0.209	0.927	0.66	1	-	2	1	96%	0.3157
8IY2_3AM_A_208	39%	57%	0.222	0.938	0.71	0.95	-	2	0	96%	0.5165
8IY2_3AM_F_206	34%	55%	0.21	0.9	0.68	1.06	-	2	5	96%	0.9565
8IY1_3AM_C_101	86%	40%	0.103	0.98	1.02	1.33	1	2	0	96%	0.3252
8IY0_3AM_C_101	79%	35%	0.126	0.981	1.1	1.46	1	4	0	96%	0.3157
3IT3_3AM_B_343	94%	11%	0.074	0.972	2.61	1.65	7	3	0	100%	1
3AGN_3AM_A_115	92%	45%	0.095	0.987	0.96	1.17	1	2	0	100%	0.9783
3AGO_3AM_A_115	73%	21%	0.139	0.968	1.45	1.85	3	7	0	100%	0.9783
3C0I_3AM_A_338	70%	4%	0.118	0.936	3.12	2.49	4	4	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.

Prepare Data

Validate Data

Deposit Data

Help and Resources

8IY2

3AM: [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] dihydrogen phosphate

3AM is a Ligand Of Interest in 8IY2 designated by the Author